Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-02

Clinical Trial Update: An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients

View source ↗

Summary

This document reports an observational study of tocilizumab (RoActemra/Actemra) used in patients with rheumatoid arthritis. The study has completed as part of R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RoActemra/Actemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED